ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 16

$229K Total Retail Price of All Prescriptions

Rank: 3 out of 16

290 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 3,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 37%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
HYDROCHLOROTHIAZIDE 318 232 1 13
LISINOPRIL 308 213 2 4
AMLODIPINE BESYLATE 272 186 3 3
SIMVASTATIN 229 170 4 5
METFORMIN HCL 134 103 5 15
VERAPAMIL ER 127 108 6 72
FUROSEMIDE 124 84 7 2
OMEPRAZOLE 112 81 8 6
METOPROLOL TARTRATE 112 76 8 7
RANITIDINE HCL 102 73 10 31
PRAVASTATIN SODIUM 93 65 11 26
TRAMADOL HCL 90 39 12 11
OXYCODONE-ACETAMINOPHEN 81 25 S2 13 28
CLONIDINE HCL 80 34 14 67
LEVOTHYROXINE SODIUM 78 72 15 1
IBUPROFEN 76 44 16 57
ATENOLOL 76 49 16 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 41 18 47
CYCLOBENZAPRINE HCL 67 0 R 19 66
PROAIR HFA 66 22 20 70
OXYCODONE HCL 62 33 S2 21 54
KLOR-CON M20 61 50 22 105
METOPROLOL SUCCINATE 59 54 23 10
ATORVASTATIN CALCIUM 58 40 24 8
GABAPENTIN 56 26 25 22
NIFEDIPINE ER 52 38 26 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.